Evaluation of the Serum Melatonin Levels in the Treatment of Patients with Multiple Sclerosis
Abstract Background: Multiple sclerosis (MS) is a myelinating inflammation and an impairment of neuronal cell regeneration in the central nervous system with unknown causes. The aim of this study was to evaluate serum melatonin levels in the treatment of patients with multiple sclerosis. Material...
Main Authors: | Abbas Alimoradian, Mohsen Shamsi, Fardin Faraji, Mehdi Ahmadi, Sayyed Ebrahim Sayyedi |
---|---|
Format: | Article |
Language: | fas |
Published: |
Arak Medical University
2018-05-01
|
Series: | Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Arāk |
Subjects: | |
Online Access: | http://amuj.arakmu.ac.ir/article-1-5484-en.pdf |
Similar Items
-
Serum levels of melatonin and cytokines in multiple sclerosis
by: Naser Farhadi, et al.
Published: (2014-04-01) -
Impact of Melatonin on Motor, Cognitive and Neuroimaging Indices in Patients with Multiple Sclerosis
by: Tina Roostaei, et al.
Published: (2015-11-01) -
A Randomized Control Trial Study to Determine the Effect of Melatonin on Serum Levels of IL-1β and TNF-α in Patients with Multiple Sclerosis
by: Masoomeh Yosefifard, et al.
Published: (2019-11-01) -
Decreased Urinary Level of Melatonin as a Marker of Disease Severity in Patients with Multiple Sclerosis
by: Taha Gholipour, et al.
Published: (2015-02-01) -
Effect of Melatonin on Serum Levels of INF-1β and Vitamin B12 in Patients With Multiple Sclerosis: A Randomized Controlled Trial
by: Masoomeh Yosefi-Fard, et al.
Published: (2020-01-01)